Menu Menu

ALNY    Alnylam Pharmaceuticals Inc    1178670    
Income Statement
Revenue alny-20241231 2,248,243,000
Net Income alny-20241231 -278,157,000
Profit Margin -12.37%

Balance Sheet
Current Assets 3,295,285,000
Assets 4,239,983,000
Current Liabilities 1,186,272,000
Liabilities 4,172,895,000
Equity 67,088,000
Shares Out 128,381,000

Cash Flow Statement
Operating Cash Flow -8,312,000
Investing Cash Flow -116,840,000

Market Analysis
Market Cap 37,449,845,386
Price 254.95
BVPS 0.52
PB 483.41
EPS -0.63
PS 4.16
FCF -125,152,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/13 -2.18
Apr May Jun
5/02 -0.16
Jul Aug Sep
8/01 0.56
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view ALNY documents filed with the SEC.


ALNY Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas